Trademark: 88028275
Status Date
Monday, September 7, 2020
Filing Date
Friday, July 6, 2018
Published for Opposition
Tuesday, December 11, 2018
Abandoned Date
Monday, September 7, 2020
5 Pharmaceuticals and medical preparations for immunotherapy, cell therapy, immune cell therapy, and T-cell therapy; pharmaceuticals and medical preparations for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system; pharmaceuticals and medical preparations of biotherapeutics, immunotherapeutics, immunomodulators, immunostimulants, immunogenics, antibodies, cell therapeutics, cells, immune cells, and T-cells
Color is not claimed as a feature of the mark.
The mark consists of stylized atom design.
Sep 8, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 7, 2020
Abandonment - No Use Statement Filed
Feb 7, 2020
Notice Of Approval Of Extension Request E-Mailed
Feb 5, 2020
Extension 2 Granted
Feb 5, 2020
Extension 2 Filed
Feb 5, 2020
Teas Extension Received
Aug 3, 2019
Notice Of Approval Of Extension Request E-Mailed
Aug 1, 2019
Extension 1 Granted
Aug 1, 2019
Extension 1 Filed
Aug 1, 2019
Teas Extension Received
Feb 5, 2019
Noa E-Mailed - Sou Required From Applicant
Jan 25, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 25, 2019
Teas Change Of Owner Address Received
Dec 11, 2018
Official Gazette Publication Confirmation E-Mailed
Dec 11, 2018
Published For Opposition
Nov 21, 2018
Notification Of Notice Of Publication E-Mailed
Oct 30, 2018
Approved For Pub - Principal Register
Oct 25, 2018
Assigned To Examiner
Jul 13, 2018
Notice Of Design Search Code E-Mailed
Jul 12, 2018
New Application Office Supplied Data Entered In Tram
Jul 10, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24